Consolidative nivolumab versus observation in unresectable stage III non-small cell lung cancer patients following neoadjuvant nivolumab plus chemotherapy and concurrent chemoradiotherapy (CA209-7AL): a randomized clinical trial.

The CA209-7AL phase 2 trial evaluated the efficacy and safety of consolidative nivolumab (NIVO) versus observation after...

Continue ReadingConsolidative nivolumab versus observation in unresectable stage III non-small cell lung cancer patients following neoadjuvant nivolumab plus chemotherapy and concurrent chemoradiotherapy (CA209-7AL): a randomized clinical trial.

Reading the Room: A Joint Perspective From a Scientist- and Patient-Partnered Working Group on the Importance of Patient-Centered Language in the Dissemination of Cancer Research.

  • Post category:Pan Cancer
  • Reading time:1 min read

The publication reports on a phase II clinical trial evaluating the efficacy and safety of a novel targeted therapy in p...

Continue ReadingReading the Room: A Joint Perspective From a Scientist- and Patient-Partnered Working Group on the Importance of Patient-Centered Language in the Dissemination of Cancer Research.

Real-world effectiveness and safety of treatment strategies for unresectable, driver-negative Stage III NSCLC: A retrospective multicentre study.

This multicenter retrospective study involving 960 patients with unresectable, driver gene-negative Stage III NSCLC from...

Continue ReadingReal-world effectiveness and safety of treatment strategies for unresectable, driver-negative Stage III NSCLC: A retrospective multicentre study.